Riskpilot← Back to searchSign inGet full accessALFA MEDICAL AS
ASActiveOrg 994450972Grini Næringspark 3, 1361 ØsteråsWholesale of pharmaceutical and medical goods · NACE 4646Est. 20092 employeeswww.alfamedical.no
Revenue 2024
NOK 8,2M
+24% vs 2023
EBITDA margin
1.8%
-37% vs 2023
Equity ratio
64.5%
Financial strength
Net profit 2024
NOK 90K
-47% vs 2023
| Revenue | NOK 8,2M | +24% |
| EBITDA | NOK 150K | -37% |
| Net profit | NOK 90K | -47% |
| Total assets | NOK 3M | +10% |
| Equity | NOK 1,9M | +5% |
| Employees | 2 | — |
Legal name
ALFA MEDICAL AS
Org number
994450972
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
7. september 2009
Share capital
NOK 150 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder og styrets leder i fellesskap.
Company purpose
Salg og service av medisinsk teknisk utstyr til offentlige og private helseinstitusjoner samt konsulentvirksomhet og deltagelse i andre selskap. Kjøp og salg av fast eiendom eller deler av denne eiendom. Leie og framleie av kontorer og lager i og utenfor oslo.
Address
Grini Næringspark 3, 1361 Østerås
Website
www.alfamedical.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 4 343 | 4 686 | 4 966 | 6 634 | 8 246 |
| Staff expenses | −1 461 | −1 140 | −654 | −1 377 | −1 544 |
| EBITDA | 17 | 286 | 774 | 238 | 150 |
| Depreciation & amort. | −0 | −2 | −0 | −20 | −8 |
| EBIT | 17 | 285 | 774 | 217 | 141 |
| Net financials | 0 | −0 | 1 | −1 | −26 |
| Profit before tax | 18 | 284 | 775 | 216 | 115 |
| Tax | 4 | 63 | 171 | 48 | 25 |
| Net profit | 14 | 221 | 605 | 168 | 90 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 464 | 1 584 | 2 180 | 2 700 | 2 979 |
| Equity | 836 | 1 057 | 1 662 | 1 830 | 1 920 |
| Long-term debt | 0 | 0 | 0 | 2 | 0 |
| Short-term debt | 628 | 526 | 518 | 868 | 1 059 |
| Total debt | 628 | 526 | 518 | 870 | 1 059 |
EBITDA margin
1.8%
This company
15.8%
Market median
-89% vs market
20202024
Equity ratio
64.5%
This company
38.2%
Market median
+69% vs market
20202024
Return on equity
4.7%
This company
18.4%
Market median
-74% vs market
20202024
Net profit margin
1.1%
This company
8.1%
Market median
-86% vs market
20202024
Asset turnover
2.77×
This company
1.12×
Market median
+147% vs market
20202024
Debt / equity
0.55×
This company
0.62×
Market median
+11% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KB Chief Executive Officer | Chief Executive Officer | 2012 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2018 | |
| Board of Directors | 2018 | |
| Chairman | 2018 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Inter-Medical As
ALFA MEDICAL AS Board members of ALFA MEDICAL AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kjell Bjarne Robøle | Chief Executive Officer | 0 companies |
| Stein Arne Snuggerud | Board of Directors | 0 companies |
| Alexander Derås Bergset | Board of Directors | 0 companies |
| Finn Øystein Kristoffersen | Chairman | 0 companies |